Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Open accessThe DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.
Abstract
Cancer tissues are composed of cancer cells and the surrounding stromal cells (e.g., fibroblasts, vascular endothelial cells, and immune cells), in addition to the extracellular matrix. Most studies investigating carcinogenesis and the progression, invasion, metastasis, and angiogenesis of cancer have focused on alterations in cancer cells, including genetic and epigenetic changes. Recently, interactions between cancer cells and the stroma have attracted considerable attention, and increasing evidence has accumulated on this. Several researchers have gradually clarified the origins, features, and roles of cancer-associated fibroblasts (CAFs), a major component of the cancer stroma. CAFs function in a similar manner to myofibroblasts during wound healing. We previously reported the relationship between CAFs and angiogenesis. Interleukin-6 (IL-6), a multifunctional cytokine, plays a central role in regulating inflammatory and immune responses, and important roles in the progression, including proliferation, migration, and angiogenesis, of several cancers. We showed that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions. Furthermore, CAFs contribute to drug-resistance acquisition in cancer cells. The interaction between cancer cells and the stroma could be a potential target for anti-cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent studies indicated that CAFs consist of several types of stromal cells that differ in their origin, functions, number, and phenotype [21, 22, 23, 24].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
Sun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., Chen, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.158 · Cited by 75
RetractedSun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., CHEN, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.224 · Cited by 40
RetractedChen, L., Qu, C., Chen, H., Xu, L., Qi, Q., Luo, J., Wang, K., Meng, Z., Chen, Z., Wang, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096177 · Cited by 30
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“This phenomenon is known as “Warburg effect” [84].”
BackgroundThe distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“proposed the theory that a “tumor is a wound that never heals” [2].”
BackgroundThe Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 2×
“These myofibroblasts acquire de novo expressed α-SMA, contractile stress fibers, and the ED-A splice variant of fibronectin [5,7].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Cited by
Items 101–200 of 814
Rick, J. W., Chandra, A., Ore, C. L. D., Nguyen, A. T., Yagnik, G., & Aghi, M. K. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.08.002 · Cited by 136
Chu, D., Nguyen, T. T. P., Tien, N. L. B., Khoa, T. D., Nguyen, T.-T., Thanh, V. V., Quang, T. L., Bui, L. M., Pham, V.-H., Ngọc, V. T. N., et al. (2019) · Cells · doi:10.3390/cells8080857 · Cited by 133
Yu, Q., Qiu, Y., Li, J., Tang, X., Wang, X., Cun, X., Xu, S., Liu, Y., Li, M., Zhang, Z., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.040 · Cited by 120
Annexin A1 as a Regulator of Immune Response in Cancer
Araújo, T. G., Mota, S. T. S., Ferreira, H. S. V., Ribeiro, M. A., Goulart, L. R., & Vecchi, L. (2021) · Cells · doi:10.3390/cells10092245 · Cited by 121
Zhu, Y., Li, X., Wang, L., Hong, X., & Yang, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.988295 · Cited by 125
Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
Wang, N., Wang, S., Li, M., Hu, B., Liu, L., Yang, S., Yang, S., Gong, Z., Lai, P. B. S., & Chen, G. G. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918816287 · Cited by 121
Mirzaei, H., Fathullahzadeh, S., Khanmohammadi, R., Darijani, M., Momeni, F., Masoudifar, A., Goodarzi, M., Mardanshah, O., Stenvang, J., Jaafari, M. R., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25799 · Cited by 116
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Czekay, R., Cheon, D., Samarakoon, R., Kutz, S. M., & Higgins, P. J. (2022) · Cancers · doi:10.3390/cancers14051231 · Cited by 128
Engineering Breast Cancer Microenvironments and 3D Bioprinting
Belgodere, J. A., King, C. T., Bursavich, J. B., Burow, M. E., Martin, E. C., & Jung, J. P. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00066 · Cited by 109
Nanoparticle Interactions with the Tumor Microenvironment
Huai, Y., Hossen, M. N., Wilhelm, S., Bhattacharya, R., & Mukherjee, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00448 · Cited by 113
Sullivan, R., Maresh, G., Zhang, X., Salomon, C., Hooper, J., Margolin, D., & Li, L. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00194 · Cited by 112
The dynamic roles of the bladder tumour microenvironment
Lee, Y., Lam, H., Rosser, C. J., Theodorescu, D., Parks, W. C., & Chan, K. S. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00608-y · Cited by 134
Xia, S., Duan, W., Liu, W., Zhang, X., & Wang, Q. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02786-6 · Cited by 116
Ansems, M., & Span, P. N. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.04.001 · Cited by 116
Hu, T., & Hu, J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1669380 · Cited by 107
Freeman, P., & Mielgo, A. (2020) · Cancers · doi:10.3390/cancers12092687 · Cited by 102
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Fernández‐Nogueira, P., Mancino, M., Fuster, G., López‐Plana, A., Jáuregui, P., Almendro, V., Enreig, E., Menéndez, S., Rojo, F., Noguera‐Castells, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0353 · Cited by 109
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
Lundberg, K. I., Treis, D., & Johnsen, J. I. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01270-8 · Cited by 111
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., Leprevost, F. D. V., Reva, B. A., Lih, T. M., Chang, H.-Y., et al. (2020) · Cell · doi:10.1016/j.cell.2019.12.026 · Cited by 120
In vitro 3d cultures to model the tumor microenvironment
Fontana, F., Marzagalli, M., Sommariva, M., Gagliano, N., & Limonta, P. (2021) · Cancers · doi:10.3390/cancers13122970 · Cited by 103
Crosstalk between cancer‐associated fibroblasts and immune cells in cancer
An, Y., Liu, F., Chen, Y., & Yang, Q. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14745 · Cited by 98
Biomaterial-Assisted Regenerative Medicine
Nii, T., & Katayama, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168657 · Cited by 107
Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression
Wang, X., Qin, X., Yan, M., Shi, J., Xu, Q., Li, Z., Yang, W., Zhang, J., & Chen, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1144-9 · Cited by 100
Wang, L., Li, X., Ren, Y., Geng, H., Zhang, Q., Cao, L., Meng, Z., Wu, X., Xu, M., & Xu, K. (2019) · Cancer Science · doi:10.1111/cas.13998 · Cited by 105
The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer
Liu, Q., Peng, F., & Chen, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163884 · Cited by 99
Murthy, D., Attri, K. S., & Singh, P. K. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00335 · Cited by 104
Nanoparticle mediated cancer immunotherapy
Gupta, J., Safdari, H. A., & Hoque, M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.015 · Cited by 101
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Samarelli, A. V., Masciale, V., Aramini, B., Coló, G. P., Tonelli, R., Marchioni, A., Bruzzi, G., Gozzi, F., Andrisani, D., Castaniere, I., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212179 · Cited by 99
Phyto-polyphenols as potential inhibitors of breast cancer metastasis
Avtanski, D. B., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0032-7 · Cited by 105
Exosome-mediated cell-cell communication in tumor progression.
Wan, Z., Gao, X., Dong, Y., Zhao, Y., Chen, X., Yang, G., & Liu, L. (2018) · Europe PMC (PubMed Central) · Cited by 108
Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stroma
Pape, J., Magdeldin, T., Stamati, K., Nyga, A., Loizidou, M., Emberton, M., & Cheema, U. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0973-9 · Cited by 96
STAT3 signaling in ovarian cancer: a potential therapeutic target
Liang, R., Chen, X., Chen, L., Wan, F., Chen, K.-H., Sun, Y., & Zhu, X. (2019) · Journal of Cancer · doi:10.7150/jca.35011 · Cited by 103
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93
Biomimetic tumor microenvironments based on collagen matrices
Sapudom, J., & Pompe, W. (2018) · Biomaterials Science · doi:10.1039/c8bm00303c · Cited by 97
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
Wondergem, N. E., Nauta, I. H., Muijlwijk, T., Leemans, C. R., & van de Ven, R. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00938-3 · Cited by 101
The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis
Shoucair, I., Mello, F. W., Jabalee, J., Maleki, S., & Garnis, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186837 · Cited by 96
Epigenetic Control of the Tumor Microenvironment
Marks, D. L., Olson, R. L., & Fernandez-Zapico, M. E. (2016) · Epigenomics · doi:10.2217/epi-2016-0110 · Cited by 92
The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
Santolla, M. F., & Maggiolini, M. (2020) · Cancers · doi:10.3390/cancers12103029 · Cited by 97
Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment
García-Gómez, A., Rodríguez‐Ubreva, J., & Ballestar, E. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.02.013 · Cited by 97
Kahounová, Z., Kurfürstová, D., Bouchal, J., Kharaishvili, G., Navrátil, J., Remšík, J., Šimečková, Š., Študent, V., Kozubík, A., & Souček, K. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23101 · Cited by 88
Prostate zones and cancer: lost in transition?
Ali, A., Feu, A. D., Oliveira, P., Choudhury, A., Bristow, R. G., & Baena, E. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00524-7 · Cited by 99
Lu, Z., Li, Y., Che, Y., Huang, J., Sun, S., Mao, S., Lei, Y., Li, N., Sun, N., & He, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.013 · Cited by 92
Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer‐associated fibroblasts
Hegab, A. E., Ozaki, M., Kameyama, N., Gao, J., Kagawa, S., Yasuda, H., Soejima, K., Yin, Y., Guzy, R. D., Nakamura, Y., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5290 · Cited by 90
Potential Application of Exosomes in Vaccine Development and Delivery
Huda, M. N., & Nurunnabi, M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-021-03143-4 · Cited by 90
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
Barriga, V., Kuol, N., Nurgali, K., & Apostolopoulos, V. (2019) · Cancers · doi:10.3390/cancers11081205 · Cited by 88
The gate to metastasis: key players in cancer cell intravasation
Sznurkowska, M. K., & Aceto, N. (2022) · The FEBS Journal · doi:10.1111/febs.16046 · Cited by 80
Ehteshami Bejnordi, B., Lin, J., Glass, B., Mullooly, M., Gierach, G. L., Sherman, M. E., Karssemeijer, N., van der Laak, J., & Beck, A. H. (2017) · 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017) · doi:10.1109/isbi.2017.7950668 · Cited by 78
Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior
Giusti, I., Francesco, M. D., Ascenzo, S. D., Palmerini, M. G., Macchiarelli, G., Carta, G., & Dolo, V. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1451286 · Cited by 82
Sun, D.-Y., Wu, J.-Q., He, Z.-H., He, M.-F., & Sun, H.-B. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116791 · Cited by 82
Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Zarrin, V., Moghadam, E. R., Hashemi, F., Makvandi, P., Samarghandian, S., Khan, H. Z., Hashemi, F., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585413 · Cited by 87
TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association
Zonneville, J., Safina, A. F., Truskinovsky, A. M., Arteaga, C. L., & Bakin, A. V. (2018) · BMC Cancer · doi:10.1186/s12885-018-4587-z · Cited by 89
Advances in Pancreatic Ductal Adenocarcinoma Treatment
Anderson, E. M., Thomassian, S., Gong, J., Hendifar, A. E., & Osipov, A. (2021) · Cancers · doi:10.3390/cancers13215510 · Cited by 88
Zheng, S., Hu, C., Lin, H., Li, G., Xia, R., Zhang, X., Su, D., Li, Z., Zhou, Q., & Chen, R. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02237-6 · Cited by 91
Thongchot, S., Ferraresi, A., Vidoni, C., Loilome, W., Yongvanit, P., Namwat, N., & Isidoro, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.031 · Cited by 88
Pleural Effusion Aspirate for Use in 3D Lung Cancer Modeling and Chemotherapy Screening
Mazzocchi, A., Devarasetty, M., Herberg, S., Petty, W. J., Marini, F., Miller, L., Kucera, G., Dukes, D. K., Ruiz, J., Skardal, A., et al. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01356 · Cited by 82
Jahangiri, B., Khalaj-kondori, M., Asadollahi, E., & Sadeghizadeh, M. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0471-5 · Cited by 78
Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
Wang, H., Pan, J., Barsky, L., Jacob, J. C., Zheng, Y., Gao, C., Wang, S., Zhu, W., Sun, H., Lu, L., et al. (2021) · Molecular Biomedicine · doi:10.1186/s43556-020-00022-z · Cited by 88
Lin, P. P. (2020) · Cells · doi:10.3390/cells9061539 · Cited by 83
Sakamoto, H., Koma, Y., Higashino, N., Kodama, T., Tanigawa, K., Shimizu, M., Fujikawa, M., Nishio, M., Shigeoka, M., Kakeji, Y., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00512-2 · Cited by 93
Strong, A. L., Pei, D. T., Hurst, C. G., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2017) · Stem Cells International · doi:10.1155/2017/9216502 · Cited by 77
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Pan, X., & Zheng, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0505-9 · Cited by 75
Yadav, M. P., Ballal, S., Martin, M., Roesch, F., Satapathy, S., Moon, E. S., Tripathi, M., Gogia, A., & Bal, C. S. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06482-z · Cited by 79
Kabir, T. D., Leigh, R. J., Tasena, H., Mellone, M., Coletta, R. D., Parkinson, E. K., Prime, S. S., Thomas, G. J., Paterson, I. C., Zhou, D., et al. (2016) · Aging · doi:10.18632/aging.100987 · Cited by 78
Jena, B. C., Das, C. K., Bharadwaj, D., & Mandal, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188416 · Cited by 80
TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment
Angioni, R., Sánchez‐Rodríguez, R., Viola, A., & Molon, B. (2021) · Cancers · doi:10.3390/cancers13030401 · Cited by 81
Zhan, S., Liu, Z., Zhang, M., Guo, T., Quan, Q., Huang, L., Guo, L., Cao, L., & Zhang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01466 · Cited by 78
Armacki, M., Polaschek, S., Waldenmaier, M., Morawe, M., Ruhland, C., Schmid, R., Lechel, A., Tharehalli, U., Steup, C., Bektas, Y., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.052 · Cited by 77
Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance
Zhao, Z., Li, T., Sun, L. L., Yuan, Y., & Zhu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115425 · Cited by 76
Hoca, M., Becer, E., Kabadayı, H., Yücecan, S., & Vatansever, S. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1670853 · Cited by 73
Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer
Worku, T., Bhattarai, D., Ayers, D., Wang, K., Wang, C., Rehman, Z. U., Talpur, H. S., & Yang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485395 · Cited by 75
Lee, S., Hong, J. H., Kim, J. S., Yoon, J. S., Chun, S. H., Hong, S. A., Kim, E. J., Kang, K., Kang, J. L., Ko, Y. H., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.021 · Cited by 75
Kim, S., Choung, S., Sun, R., Ung, N. M., Hashemi, N., Fong, E. J., Lau, R., Spiller, E. R., Gasho, J. O., Foo, J., et al. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220915827 · Cited by 73
Navashenaq, J. G., Shabgah, A. G., Banach, M., Jamialahmadi, T., Penson, P. E., Johnston, T. P., & Sahebkar, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.014 · Cited by 74
Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity
Koppensteiner, L., Mathieson, L., O’Connor, R. A., & Akram, A. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.887380 · Cited by 76
Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents
Roy, J., Hettiarachchi, S. U., Kaake, M., Mukkamala, R., & Low, P. S. (2020) · Theranostics · doi:10.7150/thno.41409 · Cited by 69
Koustoulidou, S., Hoorens, M. W. H., Dalm, S. U., Mahajan, S., Debets, R., Seimbille, Y., & de Jong, M. (2021) · Cancers · doi:10.3390/cancers13051100 · Cited by 74
Ritter, A., Kreis, N., Hoock, S. C., Solbach, C., Louwen, F., & Yuan, J. (2022) · Cancers · doi:10.3390/cancers14163908 · Cited by 72
Sasaki, K., Sugai, T., Ishida, K., Osakabe, M., Amano, H., Kimura, H. J., Sakuraba, M., Kashiwa, K., & Kobayashi, S. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.03.006 · Cited by 79
Érsek, B., Silló, P., Çakır, U., Molnár, V., Bencsik, A., Mayer, B., Mezey, É., Kárpáti, S., Pós, Z., & Németh, K. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03517-8 · Cited by 71
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Lee, S. W., Kwak, H. S., Kang, M.-H., Park, Y.-Y., & Jeong, G. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-20886-0 · Cited by 68
The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts
Liu, T., Zhou, L., YANG, K. Y., Iwasawa, K., Kadekaro, A. L., Takebe, T., Andl, T., & Zhang, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0100-7 · Cited by 74
Schmidt, M., Maié, T., Dahl, E., Costa, I. G., & Wagner, W. (2020) · BMC Biology · doi:10.1186/s12915-020-00910-4 · Cited by 76
CCN family of proteins: critical modulators of the tumor cell microenvironment
Yeger, H., & Perbal, B. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0346-6 · Cited by 70
A TRACER 3D Co-Culture tumour model for head and neck cancer
Young, M. C., Rodenhizer, D., Dean, T., D’Arcangelo, E., Xu, B., Ailles, L., & McGuigan, A. P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.038 · Cited by 70
Lawson, J., Dickman, C. T., Towle, R. M., Jabalee, J., Javer, A., & Garnis, C. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22935 · Cited by 68
Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness
Marques, P., Barry, S., Carlsen, E., Collier, D., Ronaldson, A., Awad, S., Dorward, N., Grieve, J., Mendoza, N., Muquit, S., et al. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0327 · Cited by 71
Deng, S., Cheng, D., Wang, J., Gu, J., Xue, Y., Jiang, Z., Qin, L., Mao, F., Cao, Y., & Cai, K. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02863-2 · Cited by 67
The roles and role-players in thyroid cancer angiogenesis
Rajabi, S., Dehghan, M. H., Dastmalchi, R., Mashayekhi, F. J., Salami, S., & Hedayati, M. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0537 · Cited by 68
Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis
Nee, K., Ma, D., Nguyen, Q., Pein, M., Pervolarakis, N., Insua‐Rodríguez, J., Gong, Y., Hernandez, G. A., Alshetaiwi, H. S., Williams, J., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01298-x · Cited by 69
Wang, Z., Wang, X., Zhang, T., Su, L., Liu, B., Zhu, Z., & Li, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03645-4 · Cited by 64
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
Jungwirth, U., van Weverwijk, A., Evans, R. J., Jenkins, L., Vicente, D., Alexander, J. J., Gao, Q., Haider, S., Iravani, M., & Isacke, C. M. (2021) · Nature Communications · doi:10.1038/s41467-021-23583-1 · Cited by 64
Owen, J. S., Clayton, A., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom13010067 · Cited by 66
Klymenko, Y., & Nephew, K. P. (2018) · Cancers · doi:10.3390/cancers10090295 · Cited by 65
Son, G. M., Kwon, M.-S., Shin, D., Shin, N., Ryu, D., & Kang, C. (2019) · Medicine · doi:10.1097/md.0000000000015164 · Cited by 69
Yegodayev, K. M., Novoplansky, O., Golden, A., Prasad, M., Levin, L., Jagadeeshan, S., Zorea, J., Dimitstein, O., Joshua, B., Cohen, L., et al. (2020) · Cancers · doi:10.3390/cancers12020339 · Cited by 65
Saber, S. H., Ali, H. E. A., Gaballa, R., Gaballah, M. S. A., Ali, H. I., Zerfaoui, M., & Elmageed, Z. Y. A. (2020) · Cells · doi:10.3390/cells9030564 · Cited by 64
Blise, K. E., Sivagnanam, S., Banik, G. L., Coussens, L. M., & Goecks, J. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00253-z · Cited by 67
Possible Beneficial Effects of N-Acetylcysteine for Treatment of Triple-Negative Breast Cancer
Kwon, Y. (2021) · Antioxidants · doi:10.3390/antiox10020169 · Cited by 64
p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis
Brichkina, A., Bertero, T., Loh, H. M., Nguyen, N. T. M., Emelyanov, A., Rigade, S., Ilie, M., Hofman, P., Gaggioli, C., & Bulavin, D. V. (2016) · Genes & Development · doi:10.1101/gad.290346.116 · Cited by 59
Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
Lo, C. H., & Lynch, C. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00247 · Cited by 63
Metadata
- Authors
- Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H.
- Affiliations
- Nagoya City University (JP)
- Corresponding author
- Hara, Masayasu
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2015-12-11
- Volume
- 7
- Issue
- 4
- Pages
- 2443-2458
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC4695902
- OpenAlex
- W2190528488
- Cited by
- 774
- References
- 125
- Citations by year
- 2026: 29 · 2025: 42 · 2024: 61 · 2023: 71 · 2022: 83 · 2021: 103 · 2020: 121 · 2019: 104 · 2018: 87 · 2017: 49 · 2016: 21
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor stroma, tumor-stroma interactions, angiogenesis, interleukin-6, IL-6 receptor, myofibroblasts, drug resistance, tumor progression, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.